Austria-headed biofuels and biogas process engineering company BDI BioEnergy International GmbH has announced that its proprietary RepCAT technology has received European approval as a safe disposal method for high-risk fat material.
An error occurred
On your profile you can see what subscriptions you have access to and more information.
Is some of the information wrong – please contact our customer service.
Please reload the page
Do you want to read the whole article?
- Six editions per year
- Full access to all digital content
- The E-magazine Bioenergy international
- And more ...
For decades, BDI-BioEnergy International has been committed to the development of innovative technologies. The company has been able to create technological milestones, above all, in biodiesel production from residual and waste materials.
For example, the company built the world’s first plants using waste cooking oils, animal waste fats, or grease trap fats to produce biodiesel.
Recyclable catalyst
The RepCAT process is based on a patented sustainable technology using a recyclable catalyst in biodiesel production. The RepCAT technology is used for processing raw materials with a high proportion of free fatty acids (FFA).
This innovative process can transfer raw materials containing up to 99 percent FFA. The specially developed system allows the catalyst to be reused within the process, which significantly reduces operating costs.
This important process step increases product quality while reducing the consumption of operating materials. A further advantage compared to other industrial processes is the production of absolutely salt-free glycerin of distilled quality.
EFSA approval
After several years of effort, another milestone has been achieved. BDI’s research team has succeeded in convincing the European Food Safety Agency (EFSA) that the RepCAT process is suitable for the recycling of high-risk fat materials, as defined according to EU Regulation No. 1069/2009 by EFSA.
Thus, the RepCAT process can be used to safely produce high-quality biodiesel from highly contaminated animal fats that otherwise pose a risk to the environment.
This positive assessment was based on joint trials with the renowned University Medical Center Hamburg-Eppendorf (headed by Prof. Glatzel) which led to a recognized technical publication.
Projects underway
Currently, BDI is building three large-scale industrial biodiesel plants in the USA and Europe by means of the RepCAT technology.
This success reflects our constant efforts to not only provide the best technical solution for our customers but also to positively influence the economic framework of biodiesel production so that our customers can generate a market advantage over their competitors, commented Markus Dielacher CEO of BDI.
